Elevance Health, Inc. — insider transactions

2 transactions on record · ELV · CIK 1156039

Aggregates

computed from the filings below
Purchases, 12m
2
count of open-market buys
Sales, 12m
0
count of open-market sales
Buy / sell ratio, 12m
no sales recorded
Distinct insiders, 12m
1
Bought, 3m
$1M
Sold, 3m
$0
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$753.1K
2026-07-17
Director share, 12m
100.0%
of transactions where role is stated
Current run
2 buys
consecutive same-direction transactions
Net 3m flow
$1M
purchases minus sales
Total on record
2

Transactions

2 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-172026-07-170BOUDREAUX GAILDirector, President and CEOOpen market purchase680$366.41$249.2Kfiling
2026-07-172026-07-170BOUDREAUX GAILDirector, President and CEOOpen market purchase2,045$368.25$753.1Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Elevance Health, Inc. insider transactions — 2 filings on record — Tapewire